Prospects for therapeutic use of substances from fungus Ganoderma lucidum
Abstract
The article is aimed to overview the last literature on pharmacological, preventive and therapeutic properties of the substances from fungus Ganoderma lucidum, concerning internal diseases. Anti-diabetic and anti-atherogenic effects of the G. lucidum are described, its hepato-, reno-, gastro- and cerebroprotective as well as anti-asthmatic activities are characterized. Therapeutic perspectives of G. lucidum-derived compounds are indicated.
Key words
1. Baby S., Johnson A.J., Govindan B. Secondary metabolites from Ganoderma // Phytochemistry. 2015. 114. 66-101.
2. Bhowmick B., Singh D. Novel anti-inflammatory treatments for asthma // Expert Rev. Respir. Med. 2008. 2. (5). 617-629.
3. Braun M., Pietsch P., Schror K. et al. Cellular adhesion molecules on vascular smooth muscle cells // Cardiovasc. Res. 1999. 41. (2). 395-401.
4. Busse P.J., Schofield B., Birmingham N. et al. The traditional Chinese herbal formula ASHMI inhibits allergic lung inflammation in antigen-sensitized and antigen-challenged aged mice // Ann. Allergy Asthma Immunol. 2010. 104. (3). 236-246.
5. Gao Y., Lan J., Dai X. et al. A phase I/II study of Lingzhi mushroom Ganoderma lucidum (W. Curt.: Fr.) Lloyd (Aphyllophoromycetideae) extract in patients with type II diabetes mellitus // Int. J. Med. Mushrooms. 2004. 6. 33–40.
6. Gao Y., Tang W., Gao H. et al. Ganoderma lucidum polysaccharide fractions accelerate healing of acetic acid-induced ulcers in rats // J. Med. Food. 2004. 7. (4). 417-421.
7. Gao Y., Zhou S., Wen J. et al. Mechanism of the antiulcerogenic effect of Ganoderma lucidum polysaccharides on indomethacin-induced lesions in the rat // Life Sci. 2002. 72. (6). 731-745.
8. Ha do T., Oh J., Khoi N.M. et al. In vitro and in vivo hepatoprotective effect of ganodermanontriol against t-BHP-induced oxidative stress // J. Ethnopharmacol. 2013. 150. (3). 875-885.
9. He C.Y., Li W.D., Guo S.X. et al. Effect of polysaccharides from Ganoderma lucidum on streptozotocin-induced diabetic nephropathy in mice // J. Asian Nat. Prod. Res. 2006. 8. (8). 705-711.
10. Jayaprakasam B., Yang N., Wen M.C. et al. Constituents of the anti-asthma herbal formula ASHMI(TM) synergistically inhibit IL-4 and IL-5 secretion bymurine Th2 memory cells, and eotaxin by human lung fibroblasts in vitro // J. Integr. Med. 2013. 11. (3). 195-205.
11. Kelly-Pieper K., Patil S.P., Busse P. et al. Safety and tolerability of an antiasthma herbal Formula (ASHMI) in adult subjects with asthma: a randomized, double-blinded, placebo-controlled, dose-escalation phase I study // J. Altern. Complement. Med. 2009. 15. (7). 735-743.
12. Kim D.H., Shim S.B., Kim N.J., Jang I.S. Beta-glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum // Biol. Pharm. Bull. 1999. 22. (2). 162-164.
13. Klupp N.L., Chang D., Hawke F. et al. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors // Cochrane Database Syst. Rev. 2015. 2. doi: 10.1002/14651858.CD007259.pub2.
14. Konturek P.C., Duda A, Brzozowski T. et al. Activation of genes for superoxide dismutase, interleukin-1beta, tumor necrosis factor-alpha, and intercellular adhesion molecule-1 during healing of ischemia-reperfusion-induced gastric injury // Scand. J. Gastroenterol. 2000. 35. (5). 452-463.
15. Lai K.N., Chan L.Y., Tang S.C., Leung J.C. Ganoderma extract prevents albumin-induced oxidative damage and chemokines synthesis in cultured humanproximal tubular epithelial cells // Nephrol. Dial. Transplant. 2006. 21. (5). 1188-1197.
16. Lakshmi B., Ajith T.A., Jose N., Janardhanan K.K. Antimutagenic activity of methanolic extract of Ganoderma lucidum and its effect on hepatic damage caused by benzo[a]pyrene // J. Ethnopharmacol. 2006. 107. (2). 297-303.
17. Lasukova T.V., Maslov L.N., Arbuzov A.G. et al. Cardioprotective activity of Ganoderma lucidum extract during total ischemia and reperfusion of isolated heart // Bull. Exp. Biol. Med. 2015. 158 (6). 739-741.
18. Li Y.Q. and Wang S.F. Anti-hepatitis B activities of ganoderic acid from Ganoderma lucidum // Biotechnol. Lett. 2006. 28. (11). 837-841.
19. Lin C.Y., Chen Y.H., Lin C.Y. et al. Ganoderma lucidum polysaccharides attenuate endotoxin-induced intercellular cell adhesion molecule-1 expression in cultured smooth muscle cells and in the neointima in mice // J. Agric. Food Chem. 2010. 58. (17). 9563-9571.
20. Liu C., Yang N., Song Y. et al. Ganoderic acid C1 isolated from the anti-asthma formula, ASHMI™ suppresses TNF-α production by mouse macrophages and peripheral blood mononuclear cells from asthma patients // Int. Immunopharmacol. 2015. 27. (2). 224-231.
21. Liu Y.J., Du J.L., Cao L.P. et al. Anti-inflammatory and hepatoprotective effects of Ganoderma lucidum polysaccharides on carbon tetrachloride-induced hepatocyte damage in common carp (Cyprinus carpio L.) // Immunopharmacol. 2015. 25. (1). 112-120.
22. Lu J., Sun L.X., Lin Z.B. et al. Antagonism by Ganoderma lucidum polysaccharides against the suppression by culture supernatants of B16F10 melanoma cells on macrophage // Phytother. Res. 2014. 28. (2). 200-206.
23. Ma H.T., Hsieh J.F., Chen S.T. Anti-diabetic effects of Ganoderma lucidum // Phytochemistry. 2015. 114. 109-113.
24. Min-Chang G., Wei-Hong T., Zhen X., Jie S. Effects of selenium-enriched protein from Ganoderma lucidum on the levels of IL-1 β and TNF-α, oxidative stress, and NF-κ B activation in ovalbumin-induced asthmatic mice // Evid. Based Complement. Alternat. Med. 2014. doi: 10.1155/2014/182817.
25. Misso N.L., Powers K.A., Gillon R.L. et al. Reduced platelet glutathione peroxidase activity and serum selenium concentration in atopic asthmatic patients // Clin. Exp. Allergy. 1996. 26. (7). 838-847.
26. Pan D., Zhang D., Wu J. et al. A novel proteoglycan from Ganoderma lucidum fruiting bodies protects kidney function and ameliorates diabetic nephropathy via its antioxidant activity in 57BL/6 db/db mice // Food Chem. Toxicol. 2014. 63. 111-118.
27. Pan D., Zhang D., Wu J. et al. Antidiabetic, antihyperlipidemic and antioxidant activities of a novel proteoglycan from Ganoderma lucidum fruiting bodies on db/db mice and the possible mechanism // PLoS One. 2013. 8. (7). e68332.
28. Park J.H., Jang K.J., Kim C.H. et al. Ganoderma lucidum pharmacopuncture for teating ethanol-induced chronic gastric ulcers in rats // J. Pharmacopuncture. 2015. 18. (1). 72-78.
29. Pillai T.G., John M., Sara T.G. Prevention of cisplatin induced nephrotoxicity by terpenes isolated from Ganoderma lucidum occurring in Southern Parts of India // Exp. Toxicol. Pathol. 2011. 63. (1-2). 157-160.
30. Shi Y., Sun J., He H. et al. Hepatoprotective effects of Ganoderma lucidum peptides against D-galactosamine-induced liver injury in mice // J. Ethnopharmacol. 2008. 117. (3). 415-419.
31. Shieh Y.H., Liu C.F., Huang Y.K. et al. Evaluation of the hepatic and renal-protective effects of Ganoderma lucidum in mice // Am. J. Chin. Med. 2001. 29. (3-4). 501-507.
32. Srivastava K., Sampson H.A., Emala C.W. Sr., Li X.M. The anti-asthma herbal medicine ASHMI acutely inhibits airway smooth muscle contraction via prostaglandin E2 activation of EP2/EP4 receptors // Am. J. Physiol. Lung Cell. Mol. Physiol. 2013. 305. doi: 10.1152/ajplung.00423.2012.
33. Suzuki T., Grand E., Bowman C. et al. TNF-alpha and interleukin 1 activate gastrin gene expression via MAPK- and PKC-dependent mechanisms // Am. J. Physiol. 2001. 281. (6). 1405-1412.
34. Tansey M.G. and Goldberg M.S. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention // Neurobiol. Dis. 2010. 37. (3). 510-518.
35. Teng B.S., Wang C.D., Zhang D. et al. Hypoglycemic effect and mechanism of a proteoglycan from Ganoderma lucidum on streptozotocin-induced type 2 diabetic rats // Eur. Rev. Med. Pharmacol. Sci. 2012. 16. (2). 166-175.
36. Wallace J.L. and Granger D.N. The cellular and molecular basis of gastric mucosal defense // FASEB J. 1996. 10. (7). 731-740.
37. Wang C.D., Teng B.S., He Y.M. et al. Effect of a novel proteoglycan PTP1B inhibitor from Ganoderma lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice // Br. J. Nutr. 2012. 108. (11). 2014-2025.
38. Wang F., Zhou Z., Ren X. et al. Effect of Ganoderma lucidum spores intervention on glucose and lipid metabolism gene expression profiles in type 2 diabetic rats // Lipids Health Dis. 2015. 14. doi: 10.1186/s12944-015-0045-y.
39. Wang P.Y., Zhu X.L., Lin Z.B. Antitumor and immunomodulatory effects of polysaccharides from broken-spore of Ganoderma lucidum // Front. Pharmacol. 2012. 3. doi: 10.3389/fphar.2012.00135.
40. Wang S.H., Liang C.J., Weng Y.W. et al. Ganoderma lucidum polysaccharides prevent platelet-derived growth factor-stimulated smooth muscle cell proliferation in vitro and neointimal hyperplasia in the endothelial-denuded artery in vivo // J. Cell Physiol. 2012. 227. (8). 3063-3071.
41. Wanmuang H., Leopairut J., Kositchaiwat C. et al. Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder // J. Med. Assoc. Thai. 2007. 90. (1). 179-181.
42. Wen M.C., Wei C.H., Hu Z.Q. et al. Efficacy and tolerability of anti-asthma herbal medicine intervention in adult patients with moderate-severe allergic asthma // J. Allergy Clin. Immunol. 2005. 116. (3). 517-524.
43. Wu Y.W., Fang H.L., Lin W.C. Post-treatment of Ganoderma lucidum reduced liver fibrosis induced by thioacetamide in mice // Phytother. Res. 2010. 24. (4). 494-499.
44. Yoon H.M., Jang K.J., Han M.S. et al. Ganoderma lucidum ethanol extract inhibits the inflammatory response by suppressing the NF-κB and toll-like receptor pathways in lipopolysaccharide-stimulated BV2 microglial cells // Exp. Ther. Med. 2013. 5. (3). 957-963.
45. Zhang R., Xu S., Cai Y. et al. Ganoderma lucidum protects dopaminergic neuron degeneration through inhibition of microglial activation // Evid. Based Complement. Alternat. Med. 2011. doi: 10.1093/ecam/nep075.
46. Zhang T., Srivastava K., Wen M.C. et al. Pharmacology and immunological actions of a herbal medicine ASHMI on allergic asthma // Phytother. Res. 2010. 24. (7). 1047-1055.
47. Zhang W., Zhang Q., Deng W. et al. Neuroprotective effect of pretreatment with Ganoderma lucidum in cerebral ischemia/reperfusion injury in rat hippocampus // Neural. Regen. Res. 2014. 9. (15). 1446-1452.
48. Zheng J., Yang B., Yu Y. et al. Ganoderma lucidum polysaccharides exert anti-hyperglycemic effect on streptozotocin-induced diabetic rats through affecting β-cells // Comb. Chem. High Throughput Screen. 2012. 15. (7). 542-550.
49. Zhong D., Wang H., Liu M. et al. Ganoderma lucidum polysaccharide peptide prevents renal ischemia reperfusion injury via counteracting oxidative stress // Sci. Rep. 2015. 5. doi: 10.1038/srep16910.
Petrova E.S. – candidate of technical sciences, researcher, e-mail: ekamo9@yandex.ru
Dolganova O.M. – candidate of medical sciences, researcher, e-mail: kh_olgam@mail.ru
Shvartz Ya.Sh. – doctor of medical sciences, head of the laboratory for molecular & cellular mechanisms of internal diseases, e-mail: yshschwartz@mail.ru
